The global burkholderia pseudomallei infections drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Melioidosis is also called Whitmore’s disease. It is an infectious disease that infects humans or animals and is caused by the bacterium burkholderia pseudomallei, a predominant disease of tropical climates especially in Southeast Asia and northern Australia. The major factor driving the growth of the market during the forecast period is the rising incidence of the disease across the globe.
Moreover, the disease can occur in humans and animals by inhaling contaminated dust or water droplets as well as ingestion of contaminated water along with ingestion of soil-contaminated food or another contact with contaminated soil through skin abrasions. The incubation period for the disease ranges from one day to many years, however, the symptoms starts to occur in two to four weeks after exposure.
To Request a Sample of our Report on Burkholderia Pseudomallei Infections Drug Market: https://www.omrglobal.com/request-sample/burkholderia-pseudomallei-infections-drug-market
Furthermore, as per the Center for Disease Control and Prevention (CDC), people with open skin wounds and diabetes or chronic renal disease are at high risk for melioidosis. Moreover, according to the University of California (ULCA), melioidosis causes 90,000 mortality every year globally. Hence, the rising mortalities due to melioidosis is driving the demand for the burkholderia pseudomallei infections drug market. Some key players operating in the market include Johnson & Johnson Services, Inc., Novartis International AG, and Biogen Inc., among others.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Johnson & Johnson Services, Inc., Novartis International AG, and Biogen Inc., among others
A full Report of Burkholderia Pseudomallei Infections Drug Market is Available @ https://www.omrglobal.com/industry-reports/burkholderia-pseudomallei-infections-drug-market
Global Burkholderia Pseudomallei Infections Drug Market Report by Segment
By Type
- Cholinesterase inhibitors
- Memantine
By Application
- Hospital
- Clinic
- Others
Global Burkholderia Pseudomallei Infections Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
